Article citationsMore>>

T. Kawabe, “G2 Checkpoint Abrogators as Anticancer Drugs,” Molecular Cancer Therapeutics, Vol. 3, No. 4, 2004, pp. 513-519.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top